In focus · trending topic

Skin infections

2 stories · following the connections

Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries

By Nasdaq OMXMar 2, 2017, 1:01 PM UTC

Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 Countries

By Nasdaq OMXMar 2, 2017, 1:01 PM UTC